Hsbc Holdings PLC Reduces Position in Cabot Corporation $CBT

Hsbc Holdings PLC trimmed its holdings in Cabot Corporation (NYSE:CBT) by 84.1% during the fourth quarter, HoldingsChannel reports. The firm owned 11,515 shares of the specialty chemicals company’s stock after selling 60,689 shares during the period. Hsbc Holdings PLC’s holdings in Cabot were worth $761,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Rockefeller Capital Management L.P. increased its position in shares of Cabot by 115.3% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,152 shares of the specialty chemicals company’s stock valued at $76,000 after acquiring an additional 617 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in Cabot by 76.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 944 shares of the specialty chemicals company’s stock worth $63,000 after buying an additional 410 shares in the last quarter. DGS Capital Management LLC purchased a new position in Cabot in the 4th quarter valued at approximately $206,000. Pacer Advisors Inc. grew its stake in shares of Cabot by 3,165.7% in the fourth quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock worth $15,195,000 after acquiring an additional 222,232 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. increased its position in shares of Cabot by 1.8% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 547,410 shares of the specialty chemicals company’s stock worth $36,283,000 after acquiring an additional 9,816 shares during the period. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Price Performance

Shares of CBT opened at $87.68 on Wednesday. The firm has a market capitalization of $4.53 billion, a price-to-earnings ratio of 16.57, a PEG ratio of 11.55 and a beta of 0.83. The firm’s fifty day simple moving average is $85.86 and its 200-day simple moving average is $77.50. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51.

Cabot (NYSE:CBT) last issued its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. The firm had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.30 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The company’s revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Equities analysts forecast that Cabot Corporation will post 6.34 EPS for the current fiscal year.

Cabot Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s dividend payout ratio is currently 35.73%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CBT. JPMorgan Chase & Co. increased their price objective on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research note on Wednesday, May 13th. UBS Group upped their price target on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Mizuho increased their price target on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Finally, Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $85.80.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.